Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium
- PMID: 32513628
- PMCID: PMC7269919
- DOI: 10.1016/j.oraloncology.2020.104839
Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium
Conflict of interest statement
Declaration of Competing Interest The authors declared that there is no conflict of interest.
Comment on
-
Oral Cancer Surgery and COVID pandemic - Metronomic Therapy shows a promising role while awaiting surgery.Oral Oncol. 2020 Jul;106:104814. doi: 10.1016/j.oraloncology.2020.104814. Epub 2020 May 22. Oral Oncol. 2020. PMID: 32451171 Free PMC article.
References
-
- Vermorken J.B., Remenar E., van Herpen C., Gorlia T., Mesia R., Degardin M. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007;357:1695–1704. - PubMed
-
- Lorch J.H., Goloubeva O., Haddad R.I., Cullen K., Sarlis N., Tishler R. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol. 2011;12:153–159. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
